Universität zu Köln

Dietlein, M. and Drzezga, A. (2018). Ablative Radioiodine Therapy for treating Patients with Thyroid Cancer Standardized versus personalized De-escalation of I-131 Activity. Nuklearmedizin, 57 (4). S. 118 - 124. STUTTGART: GEORG THIEME VERLAG KG. ISSN 0029-5566

Full text not available from this repository.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Dietlein, M. UNSPECIFIED UNSPECIFIED UNSPECIFIED Drzezga, A. UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-178323
DOI:	10.3413/Nukmed-0976-18-05
Journal or Publication Title:	Nuklearmedizin
Volume:	57
Number:	4
Page Range:	S. 118 - 124
Date:	2018
Publisher:	GEORG THIEME VERLAG KG
Place of Publication:	STUTTGART
ISSN:	0029-5566
Language:	German
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language RADIOACTIVE IODINE THERAPY; POSTOPERATIVE NONSTIMULATED THYROGLOBULIN; LYMPH-NODE METASTASES; HIGHER RISK FEATURES; 2ND PRIMARY-CANCER; INTERMEDIATE-RISK; EXTRATHYROIDAL EXTENSION; REMNANT ABLATION; ASSOCIATION GUIDELINES; COMPROMISED SURVIVAL Multiple languages Radiology, Nuclear Medicine & Medical Imaging Multiple languages
Refereed:	Yes
URI:	http://kups.ub.uni-koeln.de/id/eprint/17832